DEF 14A: Definitive information statements
Apr 19 16:31 ET
8-K: Current report
Apr 18 09:03 ET
Codex DNA | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 9 17:01 ET
Codex DNA | 8-K: Current report
Apr 8 16:19 ET
Codex DNA | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 3 13:48 ET
Codex DNA | 8-K: Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 28 22:41 ET
Codex DNA | 8-K: Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
Feb 26 17:02 ET
Codex DNA | 8-K: Current report
Nov 30, 2023 17:00 ET
Codex DNA | 8-K: Telesis Bio Reports Third Quarter 2023 Financial Results
Nov 13, 2023 16:32 ET
Codex DNA | 8-K: Current report
Nov 9, 2023 17:00 ET
Codex DNA | 8-K: Current report
Oct 24, 2023 16:30 ET
Codex DNA | 8-K: Current report
Sep 22, 2023 17:00 ET
Codex DNA | 8-K: Current report
Aug 29, 2023 16:02 ET
Codex DNA | 8-K: Telesis Bio Reports Second Quarter 2023 Financial Results
Aug 10, 2023 16:17 ET
Codex DNA | S-3: Registration statement for specified transactions by certain issuers
Jul 27, 2023 17:28 ET
Codex DNA | 8-K: Current report
Jul 7, 2023 16:01 ET
Codex DNA | 8-K: Current report
Jun 9, 2023 16:47 ET
Codex DNA | 8-K: Current report
May 31, 2023 17:25 ET
Codex DNA | DEFA14A: Others
May 24, 2023 16:19 ET
Codex DNA | DEF 14A: Definitive information statements
May 24, 2023 16:15 ET
No Data
No Data